We are live on ! Find out more
DCM

Driehaus Capital Management Portfolio holdings

AUM $13.6B
1-Year Est. Return 173.98%
This Fund
S&P 500
This Quarter Est. Return
+16.2%
1 Year Est. Return
+173.98%
3 Year Est. Return
+706.72%
5 Year Est. Return
+1,585.86%
10 Year Est. Return
+31,592.09%
AUM
$6.6B
AUM Growth
+$430M
Cap. Flow
+$25.1M
Cap. Flow %
0.38%
Top 10 Hldgs %
17.96%
Holding
434
New
82
Increased
115
Reduced
129
Closed
91

Top Buys

Rank Stock Value
1
CALX icon
Calix
CALX
+$48.2M
2
AXNX
Axonics, Inc. Common Stock
AXNX
+$44.8M
3
WING icon
Wingstop
WING
+$42.6M
4
EPAM icon
EPAM Systems
EPAM
+$40M
5
RBA icon
RB Global
RBA
+$38.3M

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$75.3M
2
FIVN icon
FIVE9
FIVN
+$40.4M
3
AIR icon
AAR Corp
AIR
+$34.3M
4
DOCN icon
DigitalOcean
DOCN
+$32.2M
5
XPEV icon
XPeng
XPEV
+$30.6M

Sector Composition

Rank Sector Weight
1 Healthcare 23.47%
2 Technology 20.32%
3 Industrials 15.76%
4 Consumer Discretionary 10.97%
5 Consumer Staples 8.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
JBL icon
326
Jabil
JBL
$33.4B
$272K ﹤0.01%
+4,719
New +$275K
MO icon
327
Altria Group
MO
$114B
$268K ﹤0.01%
+6,649
New +$290K
GPC icon
328
Genuine Parts
GPC
$17.7B
$260K ﹤0.01%
1,743
+117
+7% +$17.7K
ELV icon
329
Elevance Health
ELV
$83B
$253K ﹤0.01%
556
+132
+31% +$63.2K
ACN icon
330
Accenture
ACN
$101B
$252K ﹤0.01%
978
-86
-8% -$24.9K
APO icon
331
Apollo Global Management
APO
$74.6B
$246K ﹤0.01%
5,298
+1,013
+24% +$55.6K
IT icon
332
Gartner
IT
$10.1B
$239K ﹤0.01%
864
-340
-28% -$95.3K
HPQ icon
333
HP
HPQ
$24.8B
$236K ﹤0.01%
+9,452
New +$290K
TMO icon
334
Thermo Fisher Scientific
TMO
$213B
$236K ﹤0.01%
466
-38
-8% -$21.3K
DHR icon
335
Danaher
DHR
$139B
$229K ﹤0.01%
1,002
-94
-9% -$23K
KKR icon
336
KKR & Co
KKR
$95.7B
$228K ﹤0.01%
+5,294
New +$268K
T icon
337
AT&T
T
$162B
$214K ﹤0.01%
+13,973
New +$254K
PLD icon
338
Prologis
PLD
$135B
$213K ﹤0.01%
2,096
-142
-6% -$17.6K
JD icon
339
JD.com
JD
$44.6B
$205K ﹤0.01%
4,078
-11,381
-74% -$674K
ADM icon
340
Archer Daniels Midland
ADM
$37.6B
$203K ﹤0.01%
2,518
-1,328
-35% -$109K
MTG icon
341
MGIC Investment
MTG
$6.27B
$149K ﹤0.01%
+11,640
New +$163K
LUMN icon
342
Lumen
LUMN
$6.65B
$108K ﹤0.01%
14,880
+2,105
+16% +$21.4K
ABBV icon
343
AbbVie
ABBV
$433B
-1,836
Closed -$281K
ADP icon
344
Automatic Data Processing
ADP
$107B
-954
Closed -$200K
AIR icon
345
AAR Corp
AIR
$5.71B
-820,709
Closed -$34.3M
AJG icon
346
Arthur J. Gallagher & Co
AJG
$63.7B
-1,587
Closed -$259K
AMBA icon
347
Ambarella
AMBA
$3.63B
-247,059
Closed -$16.2M
ARHS icon
348
Arhaus
ARHS
$1.12B
-397,309
Closed -$1.79M
ATKR icon
349
Atkore
ATKR
$3.16B
-156,348
Closed -$13M
AVGO icon
350
Broadcom
AVGO
$1.87T
-5,490
Closed -$267K

Similar funds

Driehaus Capital Management's Q3 2022 Portfolio in Review

As of Q3 2022, Driehaus Capital Management held 434 positions worth $6.6B, up 7% from $6.17B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Driehaus Capital Management's Q3 2022 filing shows 82 new, 115 increased, 129 reduced and 91 closed positions. Its largest new stake was Axonics, Inc. Common Stock: 648,976 shares worth $45.7M. The largest sale was Pfizer, an estimated $75.3M.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 23% a quarter earlier, followed by Technology and Industrials.

  • Driehaus Capital Management's largest Q3 2022 buy was Axonics, Inc. Common Stock: 648,976 shares worth $45.7M.
  • Driehaus Capital Management added most to Calix in Q3 2022, an estimated $48.2M increase.
  • Driehaus Capital Management's biggest Q3 2022 reduction was HDFC Bank, cutting an estimated $30M.
  • Driehaus Capital Management fully exited Pfizer in Q3 2022, selling an estimated $75.3M.
  • Driehaus Capital Management's ten largest holdings make up 18% of its $6.6B portfolio in Q3 2022.
  • Driehaus Capital Management opened 82 new positions and closed 91 in Q3 2022.
  • Driehaus Capital Management's portfolio value rose 7% quarter-over-quarter to $6.6B.

Based on Driehaus Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.